A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 3, 2008, Pages 215-217

  Namazi, M R ^a,b   Jowkar, F ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immunomodulator; Leishmania; Proton pump inhibitors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIULCER AGENT; CASPASE; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CYTOCHROME C; INTERCELLULAR ADHESION MOLECULE 1; LANSOPRAZOLE; OMEPRAZOLE; PROTEIN P53; PROTON PUMP INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTATION; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PH; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NONHUMAN; NOTE; PROTEIN EXPRESSION; SENSITIZATION;

ANTI-ULCER AGENTS; ANTIGEN PRESENTATION; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTES; PROTON PUMP INHIBITORS; TRYPANOCIDAL AGENTS;

EID: 43049143513     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00907.x     Document Type: Note

References (16)

1. +)-ATPases-nature's most versatile proton pumps: review. Nat Rev Mol Cell Biol, 3, 94 103.
2. Willemijntje A, Hoogerwer F, Pankaj JP (2006) Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease. In : Laurence LB, ed. Goodman & Gilman's the pharmacological basis of therapeutics, 11th edn. New York : McGraw-Hill, Chapter 7, 621 624.
3. Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AP, Jagtap JR, Bhosale AV (2007) Recent advances in proton pump inhibitors and management of acid-peptic disorders. Bioorganic & Medicinal Chemistry, 15, 1181 1205.
4. Yeo M, Kim DK, Kim YB et al. (2004) Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res., 10, 8687 8696.
5. De Milito A, Iessi E, Logozzi M, Lozupone F (2007) Proton pump inhibitors induces apoptosis through a capsase-independent mechanism involving reactive oxygen species. Cancer Research, 67, 5408 5417.
6. Izumi H, Torigoe T, Ishiguchi H et al. (2003) Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treatment Reviews, 29, 541 549.
7. Paglin S, Hollister T, Delohery T (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Research, 61, 439 444.
8. Long X, Crow MT, Sollott SJ (1998) Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. Journal of Clinical Investigation, 101, 1453 1461.
9. Skinner-Adams TS, Davis TM, Manning LS, Johnston WA (1997) The efficacy of benzimidazoles drug against plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 580 584.
10. Kochar DK, Saini GA, Kochar SK, Sirohi PA, Bumb RA, Mehta RD, Purohit SK (2006) A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis. Journal of Vector Borne Diseases, 43, 161 167.
11. Jiang S, Meadows J, Anderson SA, Mukkada AJ (2002) Antileishmania activity of the antiulcer agent omeprazole. Antimicrobial Agents and Chemotherapy, 46, 2569 2574.
12. Sasaki T, Yamaya M, Yasuda H et al. (2005) The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. European Journal of Pharmacology, 509, 201 210.
13. Janeway CA, Travers P, Walport M, Shlomchik MJ (2005) Immunobiology, 6th edn. New York : Garland Science Publishing, 177.
14. Shafat J, Vlodavsky I, Jlan N (2006) Characterization of mechanisms involved in secretion of active heparanase. Journal of Biological Chemistry, 35, 116 127.
15. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, Kando M (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Alimentary Pharmacology and Therapeutics, 14 (Suppl 1 74 81.
16. Ohara T, Arakawa T (1999) Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Digestive Diseases and Sciences, 44, 1710 1715.